Measures include a requirement to publicly register studies and share results among research participants
News
Vitestro raises vital funding for autonomous blood drawing device
Company raises €12m in financing with a view to entering to the European market
Astellas and Pfizer reveal positive results for Xtandi
Research data follows phase 3 EMBARK trial and involves men with non-metastatic prostate cancer
AstraZeneca and MSD’s Lynparza gets green light
Combination therapy treat patients with metastatic castration-resistant prostate cancer
Genedrive’s MT-RNR1 test achieves roll out in Greater Manchester
Company will also operate work on particular initiatives across an additional five neonatal sites
Great Ormond Street Hospital and Leucid Bio collaborate
GOSH will collaborate with Leucid at the Zayed Centre for Research into Rare Disease in Children
iOnctura reveals roginolisib research results
Therapy prevents tumour proliferation while breaking immune tolerance among cancer patients
NICE approves funding for Novartis gene therapy
Funding is for onasemnogene abeparvovec and concerns babies with spinal muscular atrophy
Discovery programme launched by Cystic Fibrosis Syndicate
Aim for participants will be to quickly new antimicrobial therapies to treat chronic respiratory infections
PBD Biotech reveals vital update to TB test
Lyophilized PCR reaction bead reduces the cost of transport and extends shelf life for the test
Owlstone Medical collaborates with Bicycle Therapeutics
Duo team up for the development of antigen-targeted probes for early cancer detection
Immutep reveals initiation of pivotal Efti study
The clinical trial also involves paclitaxel in the treatment of metastatic breast cancer
Acesion announces positive atrial fibrillation study
Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a normal sinus rhythm
Vygon monitors provide improvement for ovarian cancer patients
Norfolk and Norwich University Hospitals have been using two Mostcare Up devices since 2019
IIH headaches could be treated with exenatide
The type 2 diabetes therapy is being tested on patients in a phase 2 clinical trial
